Production baseline verification recorded.
FDA PCAC reviewed a 503A bulk substance nomination in July 2026
FDA 2026 COMPOUNDING REVIEW
Emideltide / DSIP
The FDA review provides a source anchor for a peptide commonly described online under the DSIP name.
PROFESSIONAL RELEVANCE
Maintain alias mapping and separate uses considered by FDA from claims made in research marketplaces.
Product, formulation and indication
No authorised product is represented for this investigational or surveillance record. Product level data will be added only when a sourceable regulated product exists.
Status history
Future material changes will be appended with their previous status and source; they will not be silently overwritten.
Verify this record
Source labels identify what each link can prove. Sponsor material is used for time sensitive development claims only.